Drug Profile
KAN 0438757
Alternative Names: KAN-0438757Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator Kancera
- Class Antineoplastics; Small molecules
- Mechanism of Action PFKFB3 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Colorectal cancer; Pancreatic cancer; Precursor cell lymphoblastic leukaemia-lymphoma; Triple negative breast cancer
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for preclinical development in Colorectal-cancer in Sweden
- 28 Sep 2020 No recent reports of development identified for preclinical development in Pancreatic-cancer in Sweden
- 28 Apr 2020 No recent reports of development identified for preclinical development in Precursor-cell-lymphoblastic-leukaemia-lymphoma in Sweden